Global Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Reagents & Consumables
  • 1.4.3 Instruments & Accessories
  • 1.4.4 Software & Services
• 1.5 Market by Application
  • 1.5.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2020 VS 2026
  • 1.5.2 Companion Diagnostics
  • 1.5.3 Research & Development
  • 1.5.4 Clinical Diagnostics
• 1.6 Coronavirus Disease 2019 (Covid-19): Nucleic Acid-Based Multiplex Assays Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Nucleic Acid-Based Multiplex Assays Industry
    • 1.6.1.1 Nucleic Acid-Based Multiplex Assays Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Nucleic Acid-Based Multiplex Assays Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Nucleic Acid-Based Multiplex Assays Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Nucleic Acid-Based Multiplex Assays Market Perspective (2015-2026)
• 2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions
  • 2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Nucleic Acid-Based Multiplex Assays Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Nucleic Acid-Based Multiplex Assays Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Market Size
  • 3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2015-2020)
  • 3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio
  • 3.2.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2019
• 3.3 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served
• 3.4 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
• 3.5 Date of Enter into Nucleic Acid-Based Multiplex Assays Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2015-2020)
• 4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2021-2026)

5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application (2015-2026)

• 5.1 Global Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)
• 5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 6.2 Nucleic Acid-Based Multiplex Assays Key Players in North America (2019-2020)
• 6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 7.2 Nucleic Acid-Based Multiplex Assays Key Players in Europe (2019-2020)
• 7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

8 China

• 8.1 China Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 8.2 Nucleic Acid-Based Multiplex Assays Key Players in China (2019-2020)
• 8.3 China Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 8.4 China Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 9.2 Nucleic Acid-Based Multiplex Assays Key Players in Japan (2019-2020)
• 9.3 Japan Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 9.4 Japan Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 10.2 Nucleic Acid-Based Multiplex Assays Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 10.4 Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

11 India

• 11.1 India Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 11.2 Nucleic Acid-Based Multiplex Assays Key Players in India (2019-2020)
• 11.3 India Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 11.4 India Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Nucleic Acid-Based Multiplex Assays Market Size (2015-2020)
• 12.2 Nucleic Acid-Based Multiplex Assays Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Nucleic Acid-Based Multiplex Assays Market Size by Type (2015-2020)
• 12.4 Central & South America Nucleic Acid-Based Multiplex Assays Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Luminex
  • 13.1.1 Luminex Company Details
  • 13.1.2 Luminex Business Overview and Its Total Revenue
  • 13.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction
  • 13.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020))
  • 13.1.5 Luminex Recent Development
• 13.2 Thermo Fisher Scientific
  • 13.2.1 Thermo Fisher Scientific Company Details
  • 13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction
  • 13.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.2.5 Thermo Fisher Scientific Recent Development
• 13.3 Illumina
  • 13.3.1 Illumina Company Details
  • 13.3.2 Illumina Business Overview and Its Total Revenue
  • 13.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction
  • 13.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.3.5 Illumina Recent Development
• 13.4 Bio-Rad Lab
  • 13.4.1 Bio-Rad Lab Company Details
  • 13.4.2 Bio-Rad Lab Business Overview and Its Total Revenue
  • 13.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction
  • 13.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.4.5 Bio-Rad Lab Recent Development
• 13.5 QIAGEN
  • 13.5.1 QIAGEN Company Details
  • 13.5.2 QIAGEN Business Overview and Its Total Revenue
  • 13.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction
  • 13.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.5.5 QIAGEN Recent Development
• 13.6 BD
  • 13.6.1 BD Company Details
  • 13.6.2 BD Business Overview and Its Total Revenue
  • 13.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction
  • 13.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.6.5 BD Recent Development
• 13.7 Abcam
  • 13.7.1 Abcam Company Details
  • 13.7.2 Abcam Business Overview and Its Total Revenue
  • 13.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction
  • 13.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.7.5 Abcam Recent Development
• 13.8 Seegene
  • 13.8.1 Seegene Company Details
  • 13.8.2 Seegene Business Overview and Its Total Revenue
  • 13.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction
  • 13.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.8.5 Seegene Recent Development
• 13.9 Meso Scale Diagnostics
  • 13.9.1 Meso Scale Diagnostics Company Details
  • 13.9.2 Meso Scale Diagnostics Business Overview and Its Total Revenue
  • 13.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction
  • 13.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.9.5 Meso Scale Diagnostics Recent Development
• 13.10 Randox Laboratories
  • 13.10.1 Randox Laboratories Company Details
  • 13.10.2 Randox Laboratories Business Overview and Its Total Revenue
  • 13.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction
  • 13.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2015-2020)
  • 13.10.5 Randox Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer